Mosdósi B et al. |
Severe acrocyanosis precipitated by cold agglutinin secondary to infection with Mycoplasma pneumoniae in a pediatric patient. |
2017 |
Croat. Med. J. |
pmid:29308834
|
Zhang X and Hu C |
Selecting optimal columns for clarithromycin impurity analysis according to the quantitative relationship of hydrophobic subtraction model. |
2017 |
J Pharm Biomed Anal |
pmid:28024686
|
Addo KK et al. |
Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana. |
2017 |
BMC Infect. Dis. |
pmid:29197331
|
Baluch A et al. |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient. |
2017 |
Transpl Infect Dis |
pmid:27775824
|
Brouqui P et al. |
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB). |
2017 |
Int. J. Antimicrob. Agents |
pmid:28336312
|
Xu YF et al. |
and Antibacterial Activities of Patchouli Alcohol, a Naturally Occurring Tricyclic Sesquiterpene, against Helicobacter pylori Infection. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28320722
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Geng X et al. |
The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242673
|
Larsen EL et al. |
Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials. |
2017 |
Br J Clin Pharmacol |
pmid:28185274
|
Park SM et al. |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection. |
2017 |
J. Gastroenterol. Hepatol. |
pmid:27505301
|
Yoon H et al. |
Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis. |
2017 |
Gut Liver |
pmid:27282269
|
Nanishi E et al. |
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study. |
2017 |
J Am Heart Assoc |
pmid:28684643
|
Boal Carvalho P et al. |
Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting? |
2017 |
Acta Med Port |
pmid:28550827
|
Shah SA et al. |
Clarithromycin inhibits TNF-α-induced MUC5AC mucin gene expression via the MKP-1-p38MAPK-dependent pathway. |
2017 |
Int. Immunopharmacol. |
pmid:28550735
|
Osaki T et al. |
Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy. |
2017 |
Helicobacter |
pmid:28544222
|
Chang CT et al. |
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin. |
2017 |
J. Fish Dis. |
pmid:28422304
|
Jakubů V et al. |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. |
2017 |
Cent. Eur. J. Public Health |
pmid:29346850
|
Vaz AM et al. |
Capsule endoscopy in the diagnosis of disseminated complex infection. |
2017 |
BMJ Case Rep |
pmid:29167222
|
Lee H et al. |
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial. |
2017 |
Trials |
pmid:29149904
|
Sotto RB et al. |
Sub-lethal pharmaceutical hazard tracking in adult zebrafish using untargeted LC-MS environmental metabolomics. |
2017 |
J. Hazard. Mater. |
pmid:28623724
|
Liatsos C and Leontiadis GII |
The "report card" to grade H. Pylori treatment regimens: is it achievable in real-world in areas with high clarithromycin resistance? |
2017 |
J Gastrointestin Liver Dis |
pmid:28617893
|
Moon SH et al. |
Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin. |
2017 |
J. Med. Chem. |
pmid:29136469
|
Carneiro MDS et al. |
Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex. |
2017 |
Mem. Inst. Oswaldo Cruz |
pmid:29091138
|
Feng L et al. |
Removal of antibiotics during the anaerobic digestion of pig manure. |
2017 |
Sci. Total Environ. |
pmid:28628813
|
Holmberg LA et al. |
Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin. |
2017 |
Acta Haematol. |
pmid:28355602
|
Smith S et al. |
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28350745
|
Mougari F et al. |
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. |
2017 |
J. Antimicrob. Chemother. |
pmid:28333340
|
Anwar HF et al. |
Synthesis of clarithromycin ketolides chemically modified at the unreactive C10-methyl group. |
2017 |
Bioorg. Med. Chem. |
pmid:28302508
|
Fernández Martos R et al. |
Acute psychotic episode secondary to Helicobacter pylori eradication treatment. |
2017 |
Rev Esp Enferm Dig |
pmid:28071063
|
Takeuchi S et al. |
Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin. |
2017 |
BMJ Case Rep |
pmid:28069789
|
Stjepanovic MI et al. |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report. |
2016 |
Infez Med |
pmid:28011973
|
Abuhammour A et al. |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients. |
2016 |
Arab J Gastroenterol |
pmid:27665525
|
Matsumoto H et al. |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. |
2016 |
Dig. Dis. Sci. |
pmid:27659671
|
Gisbert JP |
Helicobacter pylori-related diseases. |
2016 |
Gastroenterol Hepatol |
pmid:27888863
|
Rossi A et al. |
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations. |
2016 |
Drug Dev Ind Pharm |
pmid:26065531
|
Harada T et al. |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27489022
|
Bonfigli AR et al. |
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. |
2016 |
Nutr Metab Cardiovasc Dis |
pmid:27480449
|
Orrin E et al. |
Sporotrichoid Mycobacterium chelonae. |
2016 |
Australas. J. Dermatol. |
pmid:27469486
|
Mitchell H and Katelaris P |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. |
2016 |
Med. J. Aust. |
pmid:27256648
|
Ullah S et al. |
Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. |
2016 |
Drug Deliv |
pmid:27247018
|
Kuo CH et al. |
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice. |
2016 |
Medicine (Baltimore) |
pmid:27227911
|
Sluch IM et al. |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection. |
2016 |
Cornea |
pmid:27227391
|
Matsumoto H et al. |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. |
2016 |
Helicobacter |
pmid:27061611
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Buchicchio A et al. |
Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography - high-resolution tandem mass spectrometry (FTICR MS-IRMPD). |
2016 |
Sci. Total Environ. |
pmid:27039063
|
Melia MT and Auwaerter PG |
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. |
2016 |
N. Engl. J. Med. |
pmid:27028918
|
Tepeš B et al. |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. |
2016 |
Eur J Gastroenterol Hepatol |
pmid:26862930
|
Lim SG et al. |
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use. |
2016 |
Dig Liver Dis |
pmid:26856963
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Qiu XH et al. |
Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells. |
2016 |
Acta Haematol. |
pmid:26505646
|